Literature DB >> 25901562

National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Lung Cancer Screening.

Douglas E Wood1.   

Abstract

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 25 of the world's leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. The intent of the NCCN Guidelines is to assist in the decision-making process of individuals involved in cancer care-including physicians, nurses, pharmacists, payers, patients, and their families-with the ultimate goal of advancing patient care in the fight against cancer.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early detection; Guidelines; Low-dose computed tomography; Lung cancer; Screening

Mesh：

Year:  2015        PMID： 25901562     DOI： 10.1016/j.thorsurg.2014.12.003

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  65 in total

Review 1.  A Review of Monoclonal Antibody-Based Treatments in Non-small Cell Lung Cancer.

Authors:  Yunes Panahi; Amir Hossein Mohammadzadeh; Behzad Behnam; Hossein M Orafai; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  The complicated 'Yes': Decision-making processes and receptivity to lung cancer screening among head and neck cancer survivors.

Authors:  Aaron T Seaman; Kimberly Dukes; Richard M Hoffman; Alan J Christensen; Nicholas Kendell; Andrew L Sussman; Miriam Veléz-Bermúdez; Robert J Volk; Nitin A Pagedar
Journal:  Patient Educ Couns       Date:  2018-04-22

3.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

4.  Region specific lung nodule management practice guideline.

Authors:  Scott Apperley; Stephen Lam
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

5.  Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.

Authors:  Paul F Pinsky; Barnett S Kramer
Journal:  J Natl Cancer Inst       Date:  2015-10-19       Impact factor: 13.506

6.  Yield of Low-Dose Computerized Tomography Screening for Lung Cancer in High-Risk Workers: The Case of 7189 US Nuclear Weapons Workers.

Authors:  Steven B Markowitz; Amy Manowitz; Jeffery A Miller; James S Frederick; Amaka C Onyekelu-Eze; Shannon A Widman; Lewis D Pepper; Albert Miller
Journal:  Am J Public Health       Date:  2018-08-23       Impact factor: 9.308

Review 7.  Implementation and organization of lung cancer screening.

Authors:  Jesper Holst Pedersen; Haseem Ashraf
Journal:  Ann Transl Med       Date:  2016-04

8.  What Exactly Is Shared Decision-Making? A Qualitative Study of Shared Decision-Making in Lung Cancer Screening.

Authors:  Anne C Melzer; Sara E Golden; Sarah S Ono; Santanu Datta; Kristina Crothers; Christopher G Slatore
Journal:  J Gen Intern Med       Date:  2019-11-19       Impact factor: 5.128

Review 9.  Shared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programs.

Authors:  Lisa M Lowenstein; Gary M R Deyter; Shawn Nishi; Tianhao Wang; Robert J Volk
Journal:  Transl Lung Cancer Res       Date:  2018-06

10.  Platinum Drug Sensitivity Polymorphisms in Stage III Non-small Cell Lung Cancer With Invasion of Mediastinal Lymph Nodes.

Authors:  Anca Nastase; Audrey Lupo; Victoria Laszlo; Diane Damotte; Simona Dima; Emelyne Canny; Marco Alifano; Irinel Popescu; Walter Klepetko; Madalina Grigoroiu
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.